Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population

Mostrar otras versiones (1)

BACKGROUND: Until COVID-19 drugs specifically developed to treat COVID-19 become more widely accessible, it is crucial to identify whether existing medications have a protective effect against severe disease. Towards this objective, we conducted a large population study in Clalit Health Services (CH...

Descripción completa

Detalles Bibliográficos
Autores principales: Israel, Ariel, Schäffer, Alejandro A., Cicurel, Assi, Feldhamer, Ilan, Tal, Ameer, Cheng, Kuoyuan, Sinha, Sanju, Schiff, Eyal, Lavie, Gil, Ruppin, Eytan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574266/
https://www.ncbi.nlm.nih.gov/pubmed/33083810
http://dx.doi.org/10.1101/2020.10.13.20211953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574266/
https://www.ncbi.nlm.nih.gov/pubmed/33083810
http://dx.doi.org/10.1101/2020.10.13.20211953

Ejemplares similares